+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Toxicology Testing Market by Service Type (Biochemical Assays, Cell Culture Assays, Computational Models), Technology (High Throughput Screening, Microfluidics, Organ On Chip), Application, End User - Global Forecast 2025-2030- Product Image
In-Vitro Toxicology Testing Market by Service Type (Biochemical Assays, Cell Culture Assays, Computational Models), Technology (High Throughput Screening, Microfluidics, Organ On Chip), Application, End User - Global Forecast 2025-2030- Product Image
Sale

In-Vitro Toxicology Testing Market by Service Type (Biochemical Assays, Cell Culture Assays, Computational Models), Technology (High Throughput Screening, Microfluidics, Organ On Chip), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5532927
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In vitro toxicology testing is redefining laboratory safety and efficiency across cosmetics, pharmaceutical, and chemical industries. This report provides clear insight for senior leaders navigating a landscape shaped by advanced testing platforms, regulatory expectations, and evolving supply chain strategies.

Market Snapshot: In Vitro Toxicology Testing Market Overview

The in vitro toxicology testing market grew from USD 13.49 billion in 2024 to USD 14.98 billion in 2025. It is projected to advance at a CAGR of 11.00%, reaching USD 25.24 billion by 2030. Sector momentum is propelled by demand for ethical, high-throughput, and cost-effective safety assessment options, with regulatory bodies across key regions pushing for non-animal methodologies. Industry participants are rapidly embracing innovative cell-based and computational platforms, thus setting new benchmarks for accuracy and speed in compound screening processes.

Scope & Segmentation of the In Vitro Toxicology Testing Market

  • Service Types: Biochemical assays for enzyme activity profiling, cell culture assays (including both cell line and primary cell approaches), and computational models supporting in silico predictions.
  • Technologies: High throughput screening with both assay-based and imaging-based readouts, microfluidics for precise sample handling, organ-on-chip systems bridging in vitro and in vivo environments, and three-dimensional culture methods enhancing physiological relevance.
  • Applications: Cosmetic safety testing (such as ocular and skin irritation), drug discovery (lead optimization and target validation), and safety assessments encompassing carcinogenicity, cytotoxicity, and genotoxicity studies.
  • End Users: Academic and research institutes, contract research organizations (from large-scale networks to niche CROs), and pharmaceutical and biotech companies of all sizes.
  • Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, and major emerging economies).
  • Key Companies Profiled: Charles River Laboratories, Laboratory Corporation of America Holdings, Eurofins Scientific, SGS SA, WuXi AppTec, Merck KGaA, Intertek Group, QPS Holdings, NAMSA, Inotiv.

Key Takeaways: Strategic Insights for Decision Makers

  • Shifting from conventional animal studies to advanced in vitro models enables enhanced mechanistic insights while increasing experimental consistency and reducing development timelines.
  • Technological progress, such as organ-on-chip and microfluidic systems, is delivering more accurate physiological modeling and multiplexed toxicity assessments at the cellular and subcellular levels.
  • Regulatory alignment and international harmonization efforts are fostering the adoption of standardized protocols, which are critical for cross-study comparisons and global market access.
  • Integration of artificial intelligence and big data analytics is facilitating earlier hazard detection and improved compound screening results across product development pipelines.
  • Collaborative sourcing and the formation of procurement consortia are mitigating economic pressures brought by changing trade policies.
  • Growth opportunities are emerging in regional markets where investment in laboratory infrastructure and skilled workforce development are prioritized alongside strict regulatory mandates.

Tariff Impact on Supply Chain & Operations

Tariffs introduced in 2025 on chemical reagents and lab equipment are altering procurement dynamics. Service providers and end users are reassessing supplier relationships and domestic production capacity to stabilize input costs. Collective sourcing and volume agreements are gaining traction, while strategic realignments—such as nearshoring—are strengthening market resilience amid evolving global trade considerations.

Methodology & Data Sources

The report’s findings derive from interviews with senior executives, scientific leads, and regulatory authorities, complemented by secondary reviews of technical papers, regulatory guidelines, and clinical trial data. A strict quality control process and real-world case studies anchor forecasts and validate qualitative trends observed across the sector.

The Case for This In Vitro Toxicology Testing Market Report

  • Provides actionable segmentation and technology adoption insights tailored to senior decision makers optimizing portfolios for regulatory compliance and operational agility.
  • Enables benchmarking against global and regional leaders in assay innovation, data analytics, and supply chain management.
  • Helps anticipate the operational impact of policy changes and supports data-driven decisions on partnership, investment, and expansion strategies.

Conclusion

In vitro toxicology testing is entering a transformative phase, with data science and advanced modeling fueling efficiency and regulatory acceptance. This report equips industry leaders with the strategic foundation to invest effectively, adapt operations, and harness emerging opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of organ-on-a-chip platforms for high-throughput toxicity screening in drug development
5.2. Integration of AI-driven predictive modeling within in vitro toxicology workflows for safety assessment
5.3. Expansion of three-dimensional bioprinted human tissue constructs for enhanced toxicity testing relevance
5.4. Regulatory acceptance of in vitro alternatives following OECD and FDA validation guidelines for chemical safety
5.5. Implementation of multi-organ microfluidic systems for systemic toxicity evaluation in preclinical research
5.6. Deployment of high-content imaging and automated phenotypic profiling in cell-based toxicological assays
5.7. Use of transcriptomics and multi-omics endpoints in in vitro toxicology to elucidate mechanism of action
5.8. Growing partnerships between biotech start-ups and CROs for specialized in vitro safety screening services
5.9. Adoption of stem cell-derived organoids for neurotoxicity assessment in central nervous system drug pipelines
5.10. Emergence of label-free impedance and real-time cell analysis technologies for dynamic cytotoxicity monitoring
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. In-Vitro Toxicology Testing Market, by Service Type
8.1. Introduction
8.2. Biochemical Assays
8.3. Cell Culture Assays
8.3.1. Cell Line Assays
8.3.2. Primary Cell Assays
8.4. Computational Models
9. In-Vitro Toxicology Testing Market, by Technology
9.1. Introduction
9.2. High Throughput Screening
9.2.1. Assay Based
9.2.2. Imaging Based
9.3. Microfluidics
9.4. Organ On Chip
9.5. Three Dimensional Culture
10. In-Vitro Toxicology Testing Market, by Application
10.1. Introduction
10.2. Cosmetics Testing
10.2.1. Ocular Irritation
10.2.2. Skin Irritation
10.3. Drug Discovery
10.3.1. Lead Optimization
10.3.2. Target Validation
10.4. Safety Assessment
10.4.1. Carcinogenicity
10.4.2. Cytotoxicity
10.4.3. Genotoxicity
11. In-Vitro Toxicology Testing Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.3.1. Large Scale CROs
11.3.2. Small Scale CROs
11.4. Pharma And Biotech
11.4.1. Large Pharma
11.4.2. Small And Medium Biotech
12. Americas In-Vitro Toxicology Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa In-Vitro Toxicology Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific In-Vitro Toxicology Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Charles River Laboratories International, Inc.
15.3.2. Laboratory Corporation of America Holdings
15.3.3. Eurofins Scientific SE
15.3.4. SGS SA
15.3.5. WuXi AppTec Co., Ltd.
15.3.6. Merck KGaA
15.3.7. Intertek Group plc
15.3.8. QPS Holdings, Inc.
15.3.9. NAMSA, LLC
15.3.10. Inotiv, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. IN-VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. IN-VITRO TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. IN-VITRO TOXICOLOGY TESTING MARKET: RESEARCHAI
FIGURE 24. IN-VITRO TOXICOLOGY TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. IN-VITRO TOXICOLOGY TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. IN-VITRO TOXICOLOGY TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IN-VITRO TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL LINE ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL LINE ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRIMARY CELL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRIMARY CELL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ASSAY BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ASSAY BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IMAGING BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IMAGING BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ORGAN ON CHIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ORGAN ON CHIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY THREE DIMENSIONAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY THREE DIMENSIONAL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCULAR IRRITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCULAR IRRITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SKIN IRRITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SKIN IRRITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CARCINOGENICITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CARCINOGENICITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CYTOTOXICITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CYTOTOXICITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY GENOTOXICITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY GENOTOXICITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE SCALE CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE SCALE CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL SCALE CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL SCALE CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 138. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 139. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 142. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 143. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 146. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 147. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 148. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 149. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 150. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 151. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 154. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 155. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 156. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 164. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 165. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 168. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 169. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 172. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 173. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 178. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 269. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 276. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 277. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2024 (USD MILLION)
TABLE 280. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2025-2030 (USD MILLION)
TABLE 281. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 282. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 283. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2024 (USD MILLION)
TABLE 284. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2025-2030 (USD MILLION)
TABLE 285. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 288. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2024 (USD MILLION)
TABLE 290. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2025-2030 (USD MILLION)
TABLE 291. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 292. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 293. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 298. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 299. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • SGS SA
  • WuXi AppTec Co., Ltd.
  • Merck KGaA
  • Intertek Group plc
  • QPS Holdings, Inc.
  • NAMSA, LLC
  • Inotiv, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 14.98 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.24 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Size, Share & Trends Analysis Report By Type (Cannabis Testing, Nicotine Testing) By Technology, By Application, By Method, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Size, Share & Trends Analysis Report By Type (Cannabis Testing, Nicotine Testing) By Technology, By Application, By Method, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Toxicology Testing of Daily Chemical Products & Cosmetics Market by Product Type (Haircare, Makeup, Oral Care), Testing Type (Alternative Methods, Analytical Testing, In Vitro), Service, End User, Technology - Global Forecast 2025-2030 - Product Image

Toxicology Testing of Daily Chemical Products & Cosmetics Market by Product Type (Haircare, Makeup, Oral Care), Testing Type (Alternative Methods, Analytical Testing, In Vitro), Service, End User, Technology - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
In Vitro Toxicology Testing - Global Strategic Business Report - Product Image

In Vitro Toxicology Testing - Global Strategic Business Report

  • Report
  • 159 Pages
  • Global
From
In-Vitro Toxicology Testing Market Report 2025 - Product Image

In-Vitro Toxicology Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
In-Vitro Toxicology Assays - Global Strategic Business Report - Product Image

In-Vitro Toxicology Assays - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From

About the In Vitro Toxicology Testing Market

In Vitro Toxicology Testing is a type of diagnostic testing used to assess the potential toxicity of a substance or product. It is used to evaluate the safety of a product or substance before it is released into the environment or used in humans. In Vitro Toxicology Testing is conducted in a laboratory setting, using cell cultures, animal models, and other methods to assess the potential toxicity of a substance or product. The tests are designed to identify potential adverse effects on the environment, humans, and animals. The results of the tests are used to inform decisions about the safety of a product or substance. Some companies in the In Vitro Toxicology Testing market include Charles River Laboratories, Eurofins Scientific, Covance, SGS, and Intertek. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.